Clinical Research and Quality Assurance GCP CERTIFICATE PROGRAM Your Trusted Partners for Quality Assurance and Regulatory Services
Home
WELCOME TO CRQA………
YOUR TRUSTED PARTNERS FOR REGULATORY AND AUDITING SERVICES
CRQA is an independent auditing and regulatory consulting based in Delhi, INDIA. Our services involve full range of GCP, GLP, quality assurance audits, regulatory support from feasibility to dossier submission on a global basis.


WHY ARE WE HERE………
While working in Pharmaceutical industry, Our department often felt the need to outsource GCP audits either due to resource constraints or because of specialized skills. We were always looking out for an agency who is dedicated into this space rather than outsourcing it to a CRO who offer QA along with other services. With large CROs, there were occasionally conflict of interest issues. It was seen that most of the CROs were uncomfortable to be audited by a competitor CRO.
Furthermore, every CRO and Pharma company has a QA unit but to do a reality check of their own systems and procedures, they need to be evaluated by some external auditor who could give them an holistic view of how they can do better. Overall the benefits offered are:
  • Getting the job done by skilled and experienced resources
  • No conflict of interest.
  • Cost saving as we have region based auditors who will audit the vendor/site/lab wherever it is.
  • By outsourcing the auditing job, sponsor can enjoy better relationship with the CRO.

What's New
Clinical Trial Inspections
Guidelines & procedures for planning, conducting & reporting of inspection of sponsor/ CROs, clinical trial site defined in proposed Schedule Y2

www.pharmabiz.com
EC registration
Requirements & Guidelines for registration of Ethics committees defined in proposed Schedule Y3 Mandatory criteria, record keeping & information required for registration is described Guidelines cover all ECs who review & accord their approval to a clinical trial protocol
DCGI set to form committees to formulate guidelines for Good Distribution Practices
Drugs Controller General of India (DCGI) will be setting up a committee to oversee the formulation of guidelines for the Good Distribution Practices(GDP). The decision was taken at a recently held meeting state drugs controllers.

Although the agenda was to discuss the regulations in medical devices, clinical trials and fixed drug combinations, the focus of the meet was on the need to amend the Drugs and Cosmetics Act with the addition of new schedule on Good Distribution Practices.

www.pharmabiz.com
New code for inspecting human drug trials:
Guidelines to specify who will conduct inspection, how it will be conducted and the documents required.

www.livemint.com
Clinical Trials in India:
Times of India 29th Nov.10
As per study done by Centre for studies Ethics and Rights, Mumbai and published in The Indian Journal of Medical Ethics the number of Clinical Trials is growing at 36% annually, from 2006 to 2010.The study reveals that most trials by foreign sponsor and Pharmaceutical companies are for Cancer and Circulatory System related Diseases and conducted in cities and states like Mumbai, Pune, Bangalore and Hyderabad in which Mumbai and Pune account for largest number of trials conducted in the Country.
DCGI Inspection Start Soon
Central Drug Standard Control Organization (CDSCO) today indicated for the start of a routine course of Regulatory Inspections in India. According to Drug Controller General of India (DCGI) Dr Surinder Singh the Inspections will be carried out by USFDA trained people which will assure us of the quality of data generated which will be acceptable globally and also about the volunteers safety. The notification regarding the same shall be made public within a couple of days. After the registry of clinical trials conducted in India made mandatory in 2009, the next move is registration of CRO’s.